XNK Therapeutics strengthens its scientific network with two more advisors
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Gunilla Enblad, Professor of oncology at Uppsala University, and Dr. Rizwan...
Stay updated with breaking news from Michael Uhlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Gunilla Enblad, Professor of oncology at Uppsala University, and Dr. Rizwan...
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it will perform a proof of concept study in acute myeloid leukemia (AML) using patient samples from...
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it will perform a proof of concept study in acute myeloid leukemia (AML) using patient samples from...
STOCKHOLM, Dec. 6, 2021 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it will perform a proof of concept study in acute myeloid leukemia
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced plans to further expand the scope of its proprietary technology platform of natural killer (NK)...